QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke 期刊论文 CELL DEATH & DISEASE, 2019, 卷号: 10, 页码: 18 作者:  Chen, An-Qi;  Fang, Zhi;  Chen, Xiao-Lu;  Yang, Shuai;  Zhou, Yi-Fan 收藏  |  浏览/下载：73/0  |  提交时间：2019/10/14 Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system 期刊论文 DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 卷号: 13 作者:  An, Qing;  Zheng, Yingxin;  Zhao, Yirong;  Liu, Tao;  Guo, Huaizu 收藏  |  浏览/下载：15/0  |  提交时间：2019/12/05 infliximab  biosimilar  "biobetter"  CMAB008  immunogenicity   Reduced CD27(-)IgD(-) B Cells in Blood and Raised CD27(-)IgD(-) B Cells in Gut-Associated Lymphoid Tissue in Inflammatory Bowel Disease 期刊论文 FRONTIERS IN IMMUNOLOGY, 2019, 卷号: 10 作者:  Pararasa, Chathyan;  Zhang, Na;  Tull, Thomas J.;  Chong, Ming H. A.;  Siu, Jacqueline H. Y. 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 memory B cells  inflammatory bowel disease  GALT  mass cytometry  biologics  ustekinumab  infliximab   A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects 期刊论文 BIODRUGS, 2019, 卷号: 33, 期号: 1 作者:  Zhang, Tan;  Chen, Guihong;  Liu, Chang;  Zu, Li'an;  Wang, Qi 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05 A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects 期刊论文 BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2019, 卷号: 33, 页码: 93-100 作者:  Zhang Tan[1];  Chen Guihong[2];  Liu Chang[3];  Zu Li'an[4];  Wang Qi[5] 收藏  |  浏览/下载：38/0  |  提交时间：2019/04/22 Influence of previous corticosteroid treatment on the efficacy and safety of infliximab therapy in Crohn disease 期刊论文 2019, 卷号: 98, 期号: 15, 页码: e15189 作者:  Liu, Ailing;  Li, Yue;  Yang, Hong;  Lv, Hong;  Qian, Jiaming 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 corticosteroid  Crohn disease  infliximab  loss of response  therapy   Selective prophylactic anti-tuberculosis strategy is superior for Chinese patients with inflammatory bowel disease receiving infliximab treatment: a multi-centre retrospective study 期刊论文 2019, 卷号: 13, 页码: S353-S354 作者:  Ye, L.;  Chen, M.;  Gao, X.;  Wu, K.;  Ran, Z. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03